The content on this site is intended for healthcare professionals only
For the latest
cancer COVID-19 resources, click on this link
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Brain & nervous system
cancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.
Please login or register. Then you can use this button to confirm you are part of this project.
Register for free
Already have an account?
AACR 2009: Anti-angiogenics to tackle brain and prostate tumours
Prof Gabriele Bergers - University of California, San Francisco
14 May 2009
AACR 2009: Determinants of screening colonoscopy among african-american older ad...
Prof Jean Ford - Dept of Epidemiology, Johns Hopkins University Bloomberg School...
7 May 2009
AACR 2009: Genetic influences in response to EGFR for metastatic colorectal canc...
Frederica Di Nicolantonio - Laboratory of Molecular Genetics, Institute for Canc...
1 May 2009
AACR 2009: Combined Inhibition of Histone Deacetylase and mTOR: A Novel Therapeu...
Dr Mamta Gupta - Mayo Clinic Cancer Center, USA
30 Apr 2009
Bacteria as agents to initiate potent anti-tumour activity
Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of ...
31 Mar 2009
ECCO 15 - ESMO 34 Executive Scientific Programme Committee
ECCO-ESMO Roundtable discussion - Full Version
16 Feb 2009
Flinders University, Australia
Dr. Christos Karapetis
4 Dec 2008
University Hospital Gasthuisberg
Prof. Eric Van Cutsem
4 Dec 2008
Results of the new Cetuximab studies in mCRC, from ASCO 2008
Professor Eric Van Cutsem
28 Nov 2008
Cetuximab for metastatic colorectal cancer (mCRC), from ASCO 2008
Professor Carsten Bokemeyer
27 Nov 2008